250 related articles for article (PubMed ID: 8973584)
1. Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro.
McPhee F; Caldera PS; Bemis GW; McDonagh AF; Kuntz ID; Craik CS
Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):681-6. PubMed ID: 8973584
[TBL] [Abstract][Full Text] [Related]
2. Potent HIV protease inhibitors containing a novel (hydroxyethyl)amide isostere.
Beaulieu PL; Wernic D; Abraham A; Anderson PC; Bogri T; Bousquet Y; Croteau G; Guse I; Lamarre D; Liard F; Paris W; Thibeault D; Pav S; Tong L
J Med Chem; 1997 Jul; 40(14):2164-76. PubMed ID: 9216835
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo.
Lee T; Laco GS; Torbett BE; Fox HS; Lerner DL; Elder JH; Wong CH
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):939-44. PubMed ID: 9448264
[TBL] [Abstract][Full Text] [Related]
4. Effect of biliverdin and bilirubin on the hepatic excretion of bile pigments in the rabbit.
Gonzalez J; Hidalgo F; Esteller A; Lopez MA
Comp Biochem Physiol A Comp Physiol; 1983; 74(1):67-70. PubMed ID: 6130885
[TBL] [Abstract][Full Text] [Related]
5. Chemical synthesis of a biotinylated derivative of the simian immunodeficiency virus protease. Purification by avidin affinity chromatography and autocatalytic activation.
Tomasselli AG; Bannow CA; Deibel MR; Hui JO; Zurcher-Neely HA; Reardon IM; Smith CW; Heinrikson RL
J Biol Chem; 1992 May; 267(15):10232-7. PubMed ID: 1587812
[TBL] [Abstract][Full Text] [Related]
6. An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection.
Ashorn P; McQuade TJ; Thaisrivongs S; Tomasselli AG; Tarpley WG; Moss B
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7472-6. PubMed ID: 2217178
[TBL] [Abstract][Full Text] [Related]
7. Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation.
Babé LM; Rosé J; Craik CS
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10069-73. PubMed ID: 7479728
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus protease ligand specificity conferred by residues outside of the active site cavity.
Hoog SS; Towler EM; Zhao B; Doyle ML; Debouck C; Abdel-Meguid SS
Biochemistry; 1996 Aug; 35(32):10279-86. PubMed ID: 8756683
[TBL] [Abstract][Full Text] [Related]
9. Rational design of peptide-based HIV proteinase inhibitors.
Roberts NA; Martin JA; Kinchington D; Broadhurst AV; Craig JC; Duncan IB; Galpin SA; Handa BK; Kay J; Kröhn A
Science; 1990 Apr; 248(4953):358-61. PubMed ID: 2183354
[TBL] [Abstract][Full Text] [Related]
10. Interactions of substrates and inhibitors with a family of tethered HIV-1 and HIV-2 homo- and heterodimeric proteinases.
Griffiths JT; Tomchak LA; Mills JS; Graves MC; Cook ND; Dunn BM; Kay J
J Biol Chem; 1994 Feb; 269(7):4787-93. PubMed ID: 8106448
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 protease inhibitors containing statine: inhibitory potency and antiviral activity.
Fehrentz JA; Chomier B; Bignon E; Venaud S; Chermann JC; Nisato D
Biochem Biophys Res Commun; 1992 Oct; 188(2):865-72. PubMed ID: 1445327
[TBL] [Abstract][Full Text] [Related]
12. Potency and selectivity of inhibition of human immunodeficiency virus protease by a small nonpeptide cyclic urea, DMP 323.
Erickson-Viitanen S; Klabe RM; Cawood PG; O'Neal PL; Meek JL
Antimicrob Agents Chemother; 1994 Jul; 38(7):1628-34. PubMed ID: 7979296
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the human immunodeficiency virus-1 protease and human immunodeficiency virus-1 replication by bathocuproine disulfonic acid Cu1+.
Davis DA; Branca AA; Pallenberg AJ; Marschner TM; Patt LM; Chatlynne LG; Humphrey RW; Yarchoan R; Levine RL
Arch Biochem Biophys; 1995 Sep; 322(1):127-34. PubMed ID: 7574666
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes.
Sui Z; Salto R; Li J; Craik C; Ortiz de Montellano PR
Bioorg Med Chem; 1993 Dec; 1(6):415-22. PubMed ID: 8087563
[TBL] [Abstract][Full Text] [Related]
15. Peptide inhibitors of HIV-1 and HIV-2 proteases: a comparative study.
Pichová I; Weber J; Litera J; Konvalinka J; Vondrásek J; Soucek M; Strop P; Majer P; Heuser AM; Kraeusslich HG
Leukemia; 1997 Apr; 11 Suppl 3():120-2. PubMed ID: 9209317
[TBL] [Abstract][Full Text] [Related]
16. Triterpenes as potential dimerization inhibitors of HIV-1 protease.
Quéré L; Wenger T; Schramm HJ
Biochem Biophys Res Commun; 1996 Oct; 227(2):484-8. PubMed ID: 8967903
[TBL] [Abstract][Full Text] [Related]
17. Haloperidol-based irreversible inhibitors of the HIV-1 and HIV-2 proteases.
De Voss JJ; Sui Z; DeCamp DL; Salto R; Babé LM; Craik CS; Ortiz de Montellano PR
J Med Chem; 1994 Mar; 37(5):665-73. PubMed ID: 8126707
[TBL] [Abstract][Full Text] [Related]
18. Characterization of two structurally novel HIV-1 protease inhibitors identified by rational selection.
Humblet CC; Lunney EA; Buckheit RW; Doggett C; Wong R; Antonucci TK
Antiviral Res; 1993 May; 21(1):73-84. PubMed ID: 8317922
[TBL] [Abstract][Full Text] [Related]
19. Synergistic binding of inhibitors to the protease from HIV type 1.
Asante-Appiah E; Chan WW
Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):113-7. PubMed ID: 8670094
[TBL] [Abstract][Full Text] [Related]
20. Expression of simian immunodeficiency virus (SIVmac) proteinase in E. coli.
Sugrue RJ; Wilderspin AF
Biochem Soc Trans; 1992 May; 20(2):161S. PubMed ID: 1327907
[No Abstract] [Full Text] [Related]
[Next] [New Search]
